Tetrahydrocannabinol (THC)

GW Pharmaceuticals Announces Results from Cancer Trial

February 13, 2017

On Feb. 7, 2017 GW Pharmaceuticals announced the results from a small Phase II study with tetrahydrocannabinol (THC) and cannabidiol (CBD) in 21 patients with recurrent glioblastoma multiforme (GBM).

Pages